Literature DB >> 28622478

Novel Nonsurgical Endoscopic Approaches for the Treatment of Obesity.

Ryan T Hurt1,2,3,4, Thomas H Frazier4,5, Manpreet S Mundi1.   

Abstract

Globally, obesity is a leading cause of preventable death and is associated with >60 comorbid medical conditions, including 10 types of cancer that are strongly associated with body mass index. There are a number of traditional obesity treatments-for example, lifestyle management (eg, decreased caloric intake and increased expenditure), pharmacotherapy, and bariatric surgery. Recently, endoscopic approaches have emerged as a viable alternative for weight loss. Endoscopically placed intragastric balloons were introduced in the early 1980s for the treatment of medically complicated obesity but, unfortunately, had high rates of complications, such as premature deflation leading to obstruction. Despite these shortcomings, these devices have experienced a renewal, with a second generation of improved devices being approved for clinical use in 2015. In addition to the intragastric balloons, there are a number of other endoscopic approaches to weight loss that are either Food and Drug Administration approved or undergoing evaluation (aspiration therapy, duodenal jejunal bypass sleeve). The current review examines the literature available and discusses the practical clinical considerations involved.

Entities:  

Keywords:  bariatric surgery; endoscopy; weight loss; gastric balloon; obesity

Mesh:

Year:  2017        PMID: 28622478     DOI: 10.1177/0884533617714235

Source DB:  PubMed          Journal:  Nutr Clin Pract        ISSN: 0884-5336            Impact factor:   3.080


  2 in total

Review 1.  Challenging obesity, diabetes, and addiction: the potential of lorcaserin extended release.

Authors:  Ryan T Hurt; Manpreet S Mundi; Jon O Ebbert
Journal:  Diabetes Metab Syndr Obes       Date:  2018-09-04       Impact factor: 3.168

Review 2.  The Role of Momordica charantia in Resisting Obesity.

Authors:  Meiqi Fan; Eun-Kyung Kim; Young-Jin Choi; Yujiao Tang; Sang-Ho Moon
Journal:  Int J Environ Res Public Health       Date:  2019-09-04       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.